Metabolische Myopathien: Klassifikation und Diagnostik

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von zu nutzen.

Zur Anmeldung

AutorIn: Dr. Uros Klickovic

Neuromuskuläre Arbeitsgruppe der Universitätsklinik für Neurologie, Medizinische ­Universität Wien

1 Schwartz M et al., Paternal inheritance of mitochondrial DNA. N Engl J Med 2002; 347:576–80
2 Tuppen HA et al., Mitochondrial DNA mutations and human disease. Biochim Biophys Acta 2010; 1797:113–28
3 Sarnat HB et al., Pathology of mitochondrial encephalomyopathies. Can J Neurol Sci 2005; 32:152–66
4 Laforet P et al., Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges. Neuromuscul Disord 2010; 20:693–700
5 Erguven M et al., A case of early diagnosed carnitine deficiency presenting with respiratory symptoms. Ann Nutr Metab 2007; 51:331–4
6 Deschauer M et al., Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 2005; 62:37–41
7 Corti S et al., Clinical features and new molecular findings in carnitine palmitoyltransferase II (CPT II) deficiency. J Neurolg Sci 2008; 266:97–103
8 Vockley J et al., Defects of mitochondrial beta-oxidation: a growing group of disorders. Neuromuscul Disord 2002; 12:235–46
9 Horvath R et al., Coenzyme Q10 deficency and isolated myopathy. Neurology 2006; 66:253–5
10 Oldfors A et al., New insights in the field of muscle glycogenosis. Curr Opin Neurol 2013; 26:544–53
11 Kishani PS et al., Pompe disease diagnosis and management guideline. ACMG Work Group on Management of Pompe Disease. Genet Med 2006; 8:267–288
12 Kroos MA et al., Broad spectrum of pompe disease in patients with the same c.-32-13T->G haplotype. Neurology 2007; 68:110–5
13 Kishnani PS et al., Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007; 68:99–109
14 DiMauro S et al., Muscle glycogenosis. Muscle Nerve 2001; 24:984–99
15 Vorgerd M et al., Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch Neurol 2002; 59:97–101

FdR 04|2014

Publikationsdatum: 2014-12-23